Journal Information
Vol. 17. Issue 5.
Pages 617-618 (September - October 2013)
Share
Share
Download PDF
More article options
Vol. 17. Issue 5.
Pages 617-618 (September - October 2013)
Letter to the Editor
Open Access
Etiology of bronchopulmonary infections in Bulgarian cystic fibrosis patients
Visits
4006
Tanya Stratevaa,
Corresponding author
dr.strateva@abv.bg

Corresponding author at: Department of Medical Microbiology, Faculty of Medicine, Medical University of Sofia, 2 Zdrave Street, 1431 Sofia, Bulgaria.
, Guergana Petrovab, Alexander Strateva, Penka Perenovskab, Ivan Mitova
a Department of Medical Microbiology, Faculty of Medicine, Medical University of Sofia, Bulgaria
b Pediatric Clinic, Alexandrovska University Hospital, Faculty of Medicine, Medical University of Sofia, Bulgaria
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Full Text
Dear Editor,

Cystic fibrosis (CF) is an autosomal recessive inherited disorder characterized by abnormal secretory function of all exocrine glands. Clinical symptoms vary with the severity of the disease and according to the organs involved, but the most common ones are pathological lung changes mainly presented as chronic infections. These bronchopulmonary infections (BPI) are the major reason for both progressive decreasing of lung function and mortality.

The aim of this study was to explore and analyze the etiological structure of BPI in Bulgarian CF patients according to the patient's age and gender.

During 2006–2011 period we examined 108 patients (46 females and 62 males), aged 5–27 years, with genetically confirmed CF disease. Sputum samples were plated and incubated at 37°C for 24–48h. BPI pathogens were identified by a BBL Crystal ID system (Becton Dickinson). From the sputum, genomic bacterial DNA was extracted and amplified by PCR employing two sequence-specific targets, namely (i) the Pseudomonas aeruginosa exotoxin A locus, and (ii) the Burkholderia cepacia complex recA gene using specific primers and conditions as previously described.1,2 Statistical analysis was performed by Student's t-test.

The etiologic agents of BPI are shown in Fig. 1. The leading pathogens causing BPI were P. aeruginosa and Staphylococcus aureus, followed by Candida spp., KlebsiellaEnterobacterSerratia group, and Haemophilus influenzae. Co-infection of 2 or 3 microorganisms was found in 44 patients (40.7%).

Fig. 1.

Total etiology of BPI in Bulgarian CF patients. BPI, bronchopulmonary infections; CF, cystic fibrosis.

(0.32MB).

The frequency of the infections caused by P. aeruginosa (57.4%) was very close that reported by the USA Cystic Fibrosis Foundation in 2009–2010 (51.7%). On the contrary, the frequency of S. aureus (35.2%) is lower compared to those in the USA – 51.3% (2009) and 67.0% (2010). Our established frequency of B. cepacia complex (5.5%) was slightly higher than in the USA in 2009–2010 (2.7% and 2.5% respectively), whereas the 3.3% of Stenotrophomonas maltophilia was lower (12.7% and 13.8% respectively).3,4

Regarding P. aeruginosa we found that patients of 10-years old and younger were significantly less colonized (42.1%) than patients over 16 years of age (83.3%) [p<0.01]. In the younger patients S. aureus was isolated in 42.1%, compared to 25%, among patients aged 16 years or more. Candida spp. was isolated in 21% of those aged less than 10 years and in 41.7% in adolescent/adult age group (16+ years).

In comparison with data from the USA, the rate of colonization by P. aeruginosa abruptly increases from 25% at the age of 6 years to 65% among 18 year-old patients, and up to 80% in those patients older than 25 years. Respiratory tract colonization with S. aureus (around 70% in those aged between 6 and 17 years) steadily increases up to the 10th year and then slowly decreases between the 11th and 17th year followed by a significant decrease after the age of 17 years.4

The prevalence of P. aeruginosa infections was significantly higher in girls (73.9% vs. 45.2% among boys – p<0.05). Likewise, S. aureus infections predominated among females (43.5%/29.0%) and so did Candida spp. infections (43.5%/19.4%). The frequency of BPI, caused by the KlebsiellaEnterobacterSerratia group of pathogens was similar in both genders (8.7% in girls and 12.9% in boys).

Well documented by other authors gender difference in the onset of chronic infection by P. aeruginosa – average 1 year and 7 months earlier for the girls,5 could explain higher percentage of P. aeruginosa in girls compared to the boys of our results.

A recently carried on survey of annual hospitalization records of Scandinavian CF patients aiming to search for gender differences in clinical characteristics and treatment plans revealed a higher frequency of new chronic infection by P. aeruginosa in females (30.3%) compared to males (7.1%) in a 1-year period. Furthermore, in adult female patients a higher risk for infections caused by P. aeruginosa and Burkholderia spp. was established.6

The current study confirms the global trends of the leading etiologic pathogens in the airways and the dynamic changes found in respiratory microbial flora as the CF patients age – a considerable increase in P. aeruginosa colonization and decrease in S. aureus colonization after 16 years of age. Successful eradication of the initial and subsequent BPI in the early years of CF patients improves the quality of life and survival of these individuals.

Conflict of interest

The authors declare no conflicts of interest.

References
[1]
A.A. Khan, C.E. Gerniglia.
Detection of Pseudomonas aeruginosa from clinical and environmental samples by amplification of the exotoxin A gene using PCR.
Appl Environ Microbiol, 60 (1994), pp. 3739-3745
[2]
E. Mahenthiralingam, J. Bischof, C.K. Byrne, et al.
DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III.
J Clin Microbiol, 38 (2000), pp. 3165-3173
[3]
Cystic Fibrosis Foundation.
Patient Registry: Annual Data Report 2009. Bathesda, Maryland.
(2010),
[4]
Cystic Fibrosis Foundation.
Patient Registry: Annual Data Report 2010. Bathesda, Maryland.
(2011),
[5]
C.A. Demko, P.J. Byard, P.B. Davis.
Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection.
J Clin Epidemiol, 48 (1995), pp. 1041-1049
[6]
H.V. Olesen, T. Pressler, L. Hjelte, et al.
Gender differences in the Scandinavian cystic fibrosis population.
Pediatr Pulmonol, 45 (2010), pp. 959-965
Copyright © 2013. Elsevier Editora Ltda.. All rights reserved
The Brazilian Journal of Infectious Diseases
Article options
Tools